Over three quarters of healthcare professionals call for co-created patient materials to drive engagement and trust, ...

Eli Lilly and Indiana University (IU) have announced a new agreement, under which Lilly will provide up to $40m to IU in ...

CGT Catapult, an independent technology organisation specialising in the cell and gene therapy (CGT) industry, has established ReCell, a consortium focusing on safety tests for a range of cell ...

A generation that thinks and feels differently Gen Z is the first generation to enter medicine as digital natives, but their ...

Kymera Therapeutics has announced positive results from its trial of KT-621 to treat patients with moderate to severe atopic ...

Lilly has announced plans to build a $6bn facility in Alabama in the US for the manufacture of active pharmaceutical ...

The US FDA has announced the launch of the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices ...

Pfizer has announced results from its phase 3 BASIS study of Hympavzi (marstacimab), demonstrating its success in reducing ...

Novo Nordisk has presented new findings from its phase 3 Evoke and Evoke+ trials on using semaglutide as part of Alzheimer’s ...

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and ...

Our Nature Custom Media team recently took on an ambitious project: producing a video that spanned two continents, covered a ...

Exhibitions remain one of the most powerful ways for pharmaceutical and life sciences organisations to connect, educate and ...